Sign up for the QMED & MD+DI Daily newsletter.
BioProtect Nabs $28M for Balloon Implant System Commercialization
The implantable system is biodegradable and provides rectal protection during prostate cancer radiation therapy.
September 27, 2023
1 Min Read
Image courtesy of Cision PR Newswire
BioProtect, a company providing biodegradable spacing solutions, recently announced it closed its most recent funding round with $28 million from investors. The round was led by MVM Partners, with participation from Triventures, KB Investments, Peregrine Ventures, Almeda Ventures, and Consensus Business Group of Vincent Tchenguiz. The proceeds will help support BioProtects United States commercialization of its FDA cleared BioProtect Balloon Implant System for rectal protection during prostate cancer radiation therapy.
The balloon implant system is an implantable, biodegradable balloon that provides a defined, enclosed distance to reduce radiation exposure to the rectum. It is deployed in a quick and minimally invasive procedure using a blunted tip insertion device and is visible under all imaging modalities, including CT, MRI, and ultrasound.
"We believe that our balloon has the potential to revolutionize rectal protection from radiation toxicity during prostate cancer radiation therapy," said Itay Barnea, CEO of BioProtect. "To-date, our spacer has been successfully implanted in over 2,000 patients worldwide and has proven to be safe and effective. We appreciate the support of our new and existing investors who share our vision for the company and are pleased to secure the resources to drive our penetration into the US market."
The company reported that it will officially launch the balloon technology at the 2023 annual meeting of the American Society of Therapeutic Radiology and Oncology in San Diego, CA, Oct. 1 to 4.
About the Author(s)
Managing Editor, MD+DI
Katie Hobbins is managing editor for MD+DI and joined the team in July 2022. She boasts multiple previous editorial roles in print and multimedia medical journalism, including dermatology, medical aesthetics, and pediatric medicine. She graduated from Cleveland State University in 2018 with a bachelor's degree in journalism and promotional communications. She enjoys yoga, hand embroidery, and anything DIY. You can reach her at [email protected].
You May Also Like
Pedersen's POV graphic featuring the headshot of MD+DI Senior Editor Amanda Pedersen and a pull quote from the latest edition of her opinion column.
BioSig's Ridiculously Sparse Layoff Announcement Reeks of CallousnessFeb 26, 2024|3 Min Read
Sourcing Electrical Components: Are We Back to Normal?Feb 26, 2024|6 Min Read
Your Smartwatch Can’t Measure Blood Glucose Levels… YetFeb 26, 2024|3 Min Read
Medtech in a Minute: Medtronic Pulls the Plug on Ventilators and MoreFeb 26, 2024|1 Min Read